Oct 14, 2025
Lisa C. McClain- Amount
- $1,001 to $15,000
- Filed
- Nov 21, 2025
Congress ticker disclosure profile
As of November 20 at 7:00 PM EST
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference IBKR. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
4
Disclosed ranges
$255K
Most active member desks
6 buys vs 5 sells
Latest trade Oct 14, 2025
Oct 14, 2025
Lisa C. McClainAug 13, 2025
Lisa C. McClainJun 24, 2025
Lisa C. McClainJun 17, 2025
Lisa C. McClainNov 13, 2024
Morgan McGarveyJun 6, 2024
Morgan McGarveyMay 8, 2020
Nancy PelosiDec 20, 2018
Thomas MacarthurDec 19, 2018
Thomas MacarthurDec 18, 2018
Thomas MacarthurMay 27, 2015
Thomas Macarthur| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Oct 14, 2025 | Lisa C. McClain | Sell | $1,001 to $15,000 | Nov 21, 2025 | Open card |
| Aug 13, 2025 | Lisa C. McClain | Buy | $1,001 to $15,000 | Sep 12, 2025 | Open card |
| Jun 24, 2025 | Lisa C. McClain | Sell | $1,001 to $15,000 | Aug 13, 2025 | Open card |
| Jun 17, 2025 | Lisa C. McClain | Buy | $1,001 to $15,000 | Aug 13, 2025 | Open card |
| Nov 13, 2024 | Morgan McGarvey | Sell | $1,001 to $15,000 | Dec 10, 2024 | Open card |
| Jun 6, 2024 | Morgan McGarvey | Buy | $1,001 to $15,000 | Jul 3, 2024 | Open card |
| May 8, 2020 | Nancy Pelosi | Sell | $100,001 to $250,000 | Jun 9, 2020 | Open card |
| Dec 20, 2018 | Thomas Macarthur | Buy | $1,001 to $15,000 | Jan 11, 2019 | Open card |
| Dec 19, 2018 | Thomas Macarthur | Buy | $1,001 to $15,000 | Jan 11, 2019 | Open card |
| Dec 18, 2018 | Thomas Macarthur | Buy | $1,001 to $15,000 | Jan 11, 2019 | Open card |
| May 27, 2015 | Thomas Macarthur | Sell | $1,001 to $15,000 | Jun 7, 2015 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 11 of 11 filed rows include disclosed amount ranges (100%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.